Earth Science Tech Inc. (OTC: ETST) is strategically positioning itself within the rapidly evolving telehealth industry, capitalizing on surging demand and clinical effectiveness of peptide therapies. The company, a holding firm that acquires and manages operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and consumer markets, continues to redefine its vertically integrated market position through technical innovation.
The telehealth market is projected to reach $251.5 billion by 2030, growing at a CAGR of 11.3% between 2025 and 2030, according to a report accessible at https://ibn.fm/EiRW6. ETST has positioned itself within this sector through investments in subsidiaries such as DOConsultations LLC and Las Villas Health Care Inc. The company is also capitalizing on the peptide therapy industry, expected to hit $249 billion by 2033.
ETST’s success is built on its proprietary technology and IT infrastructure, providing a significant competitive edge. By pushing innovative tech development and expanding vertical integration, the company is steadily growing its market share. Its ability to identify unique opportunities in markets projected for tremendous growth is a key driver of its strategy.
For the latest news and updates relating to ETST, the company’s newsroom is available at https://ibn.fm/ETST.
